alphaveDHANUKA₹974.60

Dhanuka Agritech Limited

Annual Quarterly₹ CrorePeersNACLIND BHAGCHEM GSPCROP BHARATRAS INSECTICID IPL MOL PUNJABCHEMMcap ₹4,393 Cr

View

In ₹ Crore except Per Share 12 Months Ending	Q1 FY23 30/06/2022	Q2 FY23 30/09/2022	Q3 FY23 31/12/2022	Q4 FY23 31/03/2023	Q1 FY24 30/06/2023	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025
Revenue from Operations	392.7	542.9	393.4	371.2	369.1	617.9	403.2	368.3	493.6	654.3	445.3	442.0
Other Income	16.9	5.5	7.7	14.7	6.6	5.8	7.3	15.3	7.1	10.8	7.0	11.2
Total Income	409.6	548.4	401.0	386.0	375.7	623.7	410.5	383.6	500.7	665.1	452.3	453.2
Expenses
+ Cost of Materials Consumed	307.9	233.4	151.3	232.9	229.3	239.8	199.9	231.0	293.5	335.9	170.7	231.6
+ Purchases of Stock-in-Trade	60.1	43.4	78.5	13.8	83.8	57.0	44.1	23.0	77.4	49.7	31.3	8.3
+ Changes in Inventories	-104.0	81.3	34.0	-17.2	-65.1	72.2	3.7	-46.4	-48.4	-7.3	65.4	10.9
+ Employee Benefit Expense	32.2	34.5	31.0	28.5	34.1	44.1	40.0	37.2	42.8	46.7	42.3	40.2
+ Finance Costs	0.8	0.8	0.8	0.8	0.9	0.8	0.7	0.7	0.8	1.1	1.4	1.8
+ Depreciation & Amortisation	3.8	4.3	4.5	5.1	4.6	9.9	12.9	13.2	12.3	12.7	13.1	17.5
+ Other Expenses	45.0	52.8	46.6	35.4	43.4	63.3	53.4	43.4	56.5	69.7	60.0	41.2
Total Expenses	345.8	450.4	346.8	299.2	331.0	487.0	354.7	302.1	435.0	508.4	384.2	351.5
EBITDA	51.5	97.5	51.8	77.9	43.6	141.6	62.2	80.1	71.7	159.6	75.6	109.7
EBIT	47.7	93.3	47.4	72.8	39.0	131.7	49.3	66.9	59.4	146.9	62.5	92.3
Profit
PBT before Exceptional Items	63.7	98.0	54.3	86.7	44.7	136.7	55.8	81.5	65.7	156.7	68.1	101.7
Pretax Income	63.7	98.0	54.3	86.7	44.7	136.7	55.8	81.5	65.7	156.7	68.1	101.7
+ Current Tax	16.6	24.7	9.3	21.7	11.6	33.3	10.7	21.3	17.7	39.4	15.7	22.7
+ Deferred Tax	-2.0	0.2	-1.1	-0.3	0.2	1.6	-0.3	1.2	-0.8	-0.2	-2.6	3.4
Tax Expense	14.6	25.0	8.2	21.4	11.8	34.9	10.5	22.5	16.8	39.1	13.0	26.2
Net Income	49.1	73.0	46.1	65.3	32.9	101.8	45.4	59.0	48.9	117.5	55.0	75.5
+ Net Income — Continuing Ops	49.1	73.0	46.1	65.3	32.9	101.8	45.4	59.0	48.9	117.5	55.0	75.5
+ Other Comprehensive Income	0.2	0.2	0.2	-0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.4
Total Comprehensive Income	49.3	73.2	46.2	64.9	32.9	101.8	45.4	60.1	48.9	117.5	55.0	76.9
Per Share
Basic EPS	10.54	15.68	9.89	14.24	7.23	22.33	9.95	12.95	10.73	25.83	12.25	16.74
Diluted EPS	10.54	15.68	9.89	14.24	7.23	22.33	9.95	12.95	10.73	25.83	12.25	16.74
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	—	—	—	—	—	1.4
+ Items NOT to be Reclassified to P&L	0.2	0.2	0.2	-0.3	0.0	0.0	—	1.4	0.0	—	—	1.9
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	—	—	—	—	—	0.5
+ Tax on Items NOT to be Reclassified — alt tag	0.0	0.0	0.0	0.0	0.0	0.0	—	0.4	0.0	0.0	0.0	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	10.54	15.68	9.89	14.24	7.23	22.33	9.95	12.95	10.73	25.83	12.25	16.74
Diluted EPS — Continuing Operations	10.54	15.68	9.89	14.24	7.23	22.33	9.95	12.95	10.73	25.83	12.25	16.74
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	128.7	184.8	129.5	141.8	121.1	249.0	155.6	160.7	171.1	276.0	177.9	191.2
Gross Margin %	32.77	34.04	32.92	38.18	32.82	40.29	38.59	43.62	34.66	42.18	39.95	43.25
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	63.7	98.0	54.3	86.7	44.7	136.7	55.8	81.5	65.7	156.7	68.1	101.7
Net Income Adj (tax-effected)	49.1	73.0	46.1	65.3	32.9	101.8	45.4	59.0	48.9	117.5	55.0	75.5
EPS Adj	10.54	15.68	9.89	14.24	7.23	22.33	9.95	12.95	10.73	25.83	12.25	16.74
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00
Paid Up Equity Capital	9.3	9.3	9.3	9.1	9.1	9.1	9.1	9.1	9.1	9.0	9.0	9.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q4 FY25 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.